-
Je něco špatně v tomto záznamu ?
Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats
V Kummer, J Maskova, Z Zraly, J Neca, P Simeckova, J Vondracek, M Machala
Jazyk angličtina Země Nizozemsko
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- alfa receptor estrogenů metabolismus MeSH
- cytochrom P-450 CYP1A1 metabolismus MeSH
- endokrinní disruptory toxicita MeSH
- epitel účinky léků MeSH
- estradiol metabolismus MeSH
- estrogeny biosyntéza MeSH
- financování organizované MeSH
- fosforylace MeSH
- hydroxylace MeSH
- imunohistochemie MeSH
- jaterní mikrozomy metabolismus účinky léků MeSH
- krysa rodu rattus MeSH
- látky znečišťující životní prostředí toxicita MeSH
- nádorový supresorový protein p53 metabolismus MeSH
- ovarium účinky léků MeSH
- polycyklické aromatické uhlovodíky toxicita MeSH
- potkani Wistar MeSH
- uterus metabolismus účinky léků MeSH
- velikost orgánu účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.
- 000
- 04104naa 2200541 a 4500
- 001
- bmc11006826
- 003
- CZ-PrNML
- 005
- 20111210203342.0
- 008
- 110406s2008 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kummer, Vladimír. $7 _AN049159
- 245 10
- $a Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats / $c V Kummer, J Maskova, Z Zraly, J Neca, P Simeckova, J Vondracek, M Machala
- 314 __
- $a Veterinary Research Institute, Brno 62132, Czech Republic.
- 520 9_
- $a Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
- 650 _2
- $a endokrinní disruptory $x toxicita $7 D052244
- 650 _2
- $a látky znečišťující životní prostředí $x toxicita $7 D004785
- 650 _2
- $a epitel $x účinky léků $7 D004848
- 650 _2
- $a estradiol $x metabolismus $7 D004958
- 650 _2
- $a alfa receptor estrogenů $x metabolismus $7 D047628
- 650 _2
- $a estrogeny $x biosyntéza $7 D004967
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hydroxylace $7 D006900
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a jaterní mikrozomy $x metabolismus $x účinky léků $7 D008862
- 650 _2
- $a velikost orgánu $x účinky léků $7 D009929
- 650 _2
- $a ovarium $x účinky léků $7 D010053
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a polycyklické aromatické uhlovodíky $x toxicita $7 D011084
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 650 _2
- $a uterus $x metabolismus $x účinky léků $7 D014599
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Mašková, Jarmila. $7 _AN050260
- 700 1_
- $a Zralý, Zdeněk. $7 uzp2009545475
- 700 1_
- $a Neča, Jiří $7 xx0079512
- 700 1_
- $a Šimečková, Pavlína. $7 xx0221392
- 700 1_
- $a Vondráček, Jan, $d 1970- $7 xx0137878
- 700 1_
- $a Machala, Miroslav $7 xx0094277
- 773 0_
- $t Toxicology Letters $w MED00004537 $g Roč. 180, č. 3 (2008), s. 212-221 $x 0378-4274
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110412131138 $b ABA008
- 991 __
- $a 20110817123445 $b ABA008
- 999 __
- $a ok $b bmc $g 834443 $s 698945
- BAS __
- $a 3
- BMC __
- $a 2008 $b 180 $c 3 $d 212-221 $i 0378-4274 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a 2011-4B/ewme